The Cabinet for Health and Family Services shall place a substance in Schedule IV if it
finds that:
(1) The substance has a low potential for abuse relative to substances in Schedule III;
(2) The substance has currently accepted medical use in treatment in the United States;
and
(3) Abuse of the substance may lead to limited physical dependence or psychological
dependence relative to the substances in Schedule III.
Effective: June 20, 2005
History: Amended 2005 Ky. Acts ch. 99, sec. 535, effective June 20, 2005. -- Amended
1998 Ky. Acts ch. 426, sec. 478, effective July 15, 1998. -- Amended 1974 Ky. Acts
ch. 74, Art VI, sec. 107(3). -- Created 1972 Ky. Acts ch. 226, sec. 11.
Notes of Decisions
Commonwealth v. Grubb, 862 S.W.2d 883 (Ky. 1993).
· cites it 2× “080 and also KRS 218A.100. The enumerated differences between Schedule III and Schedule IV types of controlled substances are self-evident.”
Kroth v. Commonwealth, 737 S.W.2d 680 (Ky. 1987).
· cites it 2× “080 and KRS 218A.100 state the differences between Schedule III and Schedule IV types of controlled substances.”
Commonwealth v. Hamilton, 411 S.W.3d 741 (Ky. 2013).
“The Court acknowledged the defendant's argument that the Cabinet had failed to state the statutorily required findings in the regulation.”
Shelton v. Commonwealth, 928 S.W.2d 817 (Ky. Ct. App. 1996).
“080, and Schedule IV drugs, as defined in KRS 218A.100. It held that no double jeopardy violation existed because the appellant’s possession of these drugs constituted a violation of separate statutory provisions.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.